Clinical Trial Update: Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in the Parkinson's Progression Markers Initiative is evaluating early longitudinal brain imaging with the PET tracer 18F-AV-133 in prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• [18F] AV-133 (AV-133)

Snippet

Sponsor: Michael J. Fox Foundation for Parkinson's Research | Conditions: Prodromal Parkinsons Disease | Phase 2 | Status: RECRUITING